Rejuvenation Technologies Inc.
YC S18 ↗San Francisco, US · Founded 2016 · 2 employees · 3 known investors
Rejuvenation develops proprietary mRNA and lipid nanoparticle technology to safely lengthen telomeres in human cells, targeting cellular aging and diseases caused by short telomeres including pulmonary fibrosis, liver disease, and bone marrow failure.
BiotechDeep TechHealthtechLongevityAnti-AgingGene TherapyNanomedicinein /company@ycombinatorycombinator.com ↗
Founders & leadership· Y Combinator alumni (S18)
GM
Glenn MarkovinFounder
JR
John RamunasinFounder
